We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cephalon Pays $444 Million for Off-Label Marketing
Cephalon Pays $444 Million for Off-Label Marketing
January 14, 2009
Last October, Cephalon agreed to a $444 million settlement of federal and state investigations in which officials accused it of off-label marketing of three drugs.